Total Payments
$5,227
2024 Payments
$1,215
Companies
30
Transactions
352
Medicare Patients
6,471
Medicare Billing
$472,845
Payment Breakdown by Category
Food & Beverage$5,127 (98.1%)
Education$99.95 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,127 | 351 | 98.1% |
| Education | $99.95 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,367 | 115 | $0 (2024) |
| Janssen Biotech, Inc. | $697.11 | 39 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $641.92 | 45 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $619.22 | 46 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $279.64 | 15 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $256.48 | 15 | $0 (2024) |
| Allergan Inc. | $212.93 | 15 | $0 (2019) |
| Celgene Corporation | $141.67 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $113.87 | 7 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $110.79 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,215 | 85 | ABBVIE INC. ($394.29) |
| 2023 | $1,196 | 81 | AbbVie Inc. ($416.49) |
| 2022 | $909.60 | 64 | ABBVIE INC. ($204.82) |
| 2021 | $551.16 | 32 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($163.30) |
| 2020 | $144.30 | 9 | AbbVie Inc. ($51.81) |
| 2019 | $585.92 | 40 | Allergan Inc. ($156.41) |
| 2018 | $308.59 | 22 | Gilead Sciences, Inc. ($63.36) |
| 2017 | $316.65 | 19 | AbbVie, Inc. ($110.93) |
All Payment Transactions
352 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: LIVER DISEASE | ||||||
| 11/06/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: VIROLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Gastroenterology | ||||||
| 09/24/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: VIROLOGY | ||||||
| 09/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,273 | 1,673 | $495,489 | $106,114 |
| 2022 | 30 | 1,670 | 2,184 | $569,940 | $121,318 |
| 2021 | 28 | 1,647 | 2,141 | $562,456 | $122,244 |
| 2020 | 36 | 1,881 | 2,435 | $542,201 | $123,169 |
Total Patients
6,471
Total Services
8,433
Medicare Billing
$472,845
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 238 | 242 | $232,078 | $47,866 | 20.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 173 | 362 | $45,204 | $8,012 | 17.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 127 | 133 | $71,288 | $7,944 | 11.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 75 | $16,125 | $5,823 | 36.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 46 | 108 | $12,034 | $5,267 | 43.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 59 | 81 | $11,259 | $4,926 | 43.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 68 | $10,200 | $4,120 | 40.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 30 | 31 | $12,958 | $3,511 | 27.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 41 | 41 | $34,775 | $3,441 | 9.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 19 | 19 | $15,295 | $3,310 | 21.6% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 42 | 43 | $5,728 | $2,600 | 45.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $4,340 | $2,001 | 46.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $10,465 | $1,559 | 14.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 17 | $2,771 | $1,556 | 56.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 26 | 28 | $2,296 | $812.28 | 35.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 66 | 93 | $930.00 | $781.20 | 84.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 39 | 39 | $1,677 | $576.42 | 34.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 37 | 73 | $1,752 | $555.53 | 31.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 34 | 54 | $1,296 | $447.66 | 34.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 18 | 29 | $928.00 | $300.15 | 32.3% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 14 | 15 | $615.00 | $200.40 | 32.6% |
| 83550 | Iron binding capacity | Office | 2023 | 15 | 16 | $400.00 | $137.12 | 34.3% |
| 83735 | Magnesium level | Office | 2023 | 18 | 18 | $342.00 | $118.26 | 34.6% |
| 83540 | Iron level | Office | 2023 | 15 | 16 | $288.00 | $101.44 | 35.2% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 17 | 19 | $285.00 | $96.52 | 33.9% |
About Dr. Sara Echelmeyer, M.D
Dr. Sara Echelmeyer, M.D is a Gastroenterology healthcare provider based in Jefferson City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346220746.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sara Echelmeyer, M.D has received a total of $5,227 in payments from pharmaceutical and medical device companies, with $1,215 received in 2024. These payments were reported across 352 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,127).
As a Medicare-enrolled provider, Echelmeyer has provided services to 6,471 Medicare beneficiaries, totaling 8,433 services with total Medicare billing of $472,845. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Jefferson City, MO
- Active Since 01/20/2006
- Last Updated 01/14/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1346220746
Products in Payments
- STELARA (Biological) $636.94
- RINVOQ (Biological) $452.26
- XIFAXAN (Drug) $375.71
- ENTYVIO (Biological) $372.18
- SKYRIZI (Biological) $262.54
- OCALIVA (Drug) $256.48
- ZEPOSIA (Drug) $252.46
- LINZESS (Drug) $240.70
- TRULANCE (Drug) $239.05
- ZENPEP (Drug) $224.18
- Humira (Biological) $202.33
- VOWST (Biological) $152.01
- Entyvio (Biological) $146.67
- CREON (Drug) $124.50
- DIFICID (Drug) $113.87
- MAVYRET (Drug) $86.57
- VIBERZI (Drug) $85.54
- INJECTAFER (Drug) $82.63
- Cimzia (Drug) $76.01
- DUPIXENT (Biological) $70.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.